Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1

general

An acute myeloid leukemia (AML) associated with t(8;21)(q22;q22) resulting in RUNX1-RUNX1T1 fusion protein expression. This is seen in 12% of children with AML.

31

Centers

0

Active Trials

$7.1B

Cancer Funding

Specific Cancer Types(1)

Top Centers for Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1(31)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
54.5
254.5
3
NCI Comprehensive
54.5
4
NCI Comprehensive
54.5
5
NCI Comprehensive
54.5
654.5
754.5
854.5
954.5
1054.5
1154.5
12
NCI Comprehensive
13
NCI Comprehensive
14
15
NCI Comprehensive
16
NCI Comprehensive
17
18
19
NCI Comprehensive
20
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
21
NCI Comprehensive
22
NCI Comprehensive
23
NCI Comprehensive
24
NCI Comprehensive
25
NCI Comprehensive
26
27
28
NCI Comprehensive
29
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
30
31

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →